Medical Question

Patient: 71-year-old with an Aveir VR leadless pacemaker

Scenario: A patient 71 years old with an Aveir VR LP starts the day at 4 AM with 60 minutes of exercise, followed by 4 hours of driving and two work meetings. The patient goes to bed at 9:30 PM after drinking 250 ml of soy milk, almond milk and water. He goes to sleep in the right lateral position. At that moment he has a heart rate of 50 bpm, SpO2 of 98 and a perfusion index of 4.5. After 5 hours of deep sleep (2:30 AM) the patient wakes up with a heart rate of 27 beats per minute, SpO2 of 95 and perfusion index of 20. Then he goes to bathroom to urinate 50 ml when normally urinates 250 ml. From 2:30 to 3:00 AM the patient is in bed with no symptoms at all and SpO2 of 95, heart rate of 27 beats per minute and perfusion index of 20. He drinks 100 ml of water. Around 3:00 AM the patient falls asleep again and wake up at 6 AM with a big discomfort, close to pain and a heart rate of 50 beats per minute, SpO2 of 97 and PI of 5. He goes to urinate, and the amount of urine is 50 ml when usually at that time of the day is 150 ml. The big discomfort remains until the patient goes to the swimming pool when he swims 30 minutes with no pain or any discomfort.

My question to you: What happens in the hours the patient was sleeping?

Medical Analysis: Nocturnal Cardiovascular Event in Pacemaker Patient

Key Timeline of Nocturnal Events

9:30 PM (Bedtime): HR 50 bpm, SpO₂ 98%, PI 4.5

2:30 AM (After 5h sleep): HR 27 bpm, SpO₂ 95%, PI 20

2:30-3:00 AM: Asymptomatic despite HR 27 bpm, PI 20

6:00 AM (Morning): "Big discomfort", HR 50 bpm, SpO₂ 97%, PI 5

After swimming: Symptoms completely resolve

Primary Diagnosis

This pattern is highly suggestive of a Nocturnal (Sleep-Related) Vasovagal Syncope or Profound Vasodepressor Response, with critical interaction from the patient's Aveir VR Leadless Pacemaker.

IMPORTANT: This is a potentially serious finding that requires urgent medical evaluation. The patient should contact their cardiologist or electrophysiologist immediately.

The Physiological Sequence During Sleep

1. Trigger During Deep Sleep (Around 2:30 AM)

During deep sleep (slow-wave sleep), a pronounced increase in vagal (parasympathetic) tone occurs naturally. In susceptible individuals, this can trigger a vasovagal response.

2. The Vasovagal Cascade

Cardioinhibition: The vagal surge causes dramatic slowing of the heart's intrinsic rate. The pacemaker is appropriately sensing this intrinsic bradycardia and pacing the ventricle at 27 bpm. This indicates the patient's underlying native heart rate dropped below the pacemaker's lower limit.
Vasodepression: Simultaneous failure of sympathetic compensation leads to widespread vasodilation, explaining the surge in Perfusion Index (PI to 20)—blood is pooling in the extremities.

3. Physiological Consequences

Hypotension: The combination of bradycardia and vasodilation causes significant blood pressure drop.
Reduced Organ Perfusion: The brain and kidneys are particularly sensitive. The reduced urine output (50 ml vs. 250 ml at 2:30 AM and 50 ml vs. 150 ml at 6 AM) indicates the body is conserving fluid due to low blood pressure.
Symptom Delay Mechanism: The patient wakes at 2:30 AM asymptomatic because arousal interrupted the full syncope cycle. The severe discomfort at 6 AM likely represents the blood pressure normalizing phase (vasoconstriction, PI dropping from 20 to 5), which can feel unsettling due to catecholamine release.

Critical Device-Specific Factor: The Aveir VR Pacemaker

The Aveir VR is a single-chamber ventricular pacemaker with no atrial sensing or pacing capability. During a vasovagal event with atrial bradycardia, this device cannot maintain atrioventricular synchrony (coordinated atrial and ventricular contraction). Loss of the "atrial kick" can reduce cardiac output by 20-30%, worsening the hypotension from vasodilation. The paced rate of 27 bpm, while preventing asystole, is hemodynamically insufficient during such an event.

Recommended Clinical Actions

1. Immediate Device Interrogation (MOST CRITICAL)

The pacemaker's stored data will provide definitive evidence:

Heart rate trends throughout the night
Pacing logs and percentage
Intracardiac electrograms from the event
Documentation of the onset, duration, and resolution of bradycardia

2. Possible Device Reprogramming

Increase the lower rate limit (e.g., from 50 to 60 bpm) for better nocturnal support
Activate or adjust a "Rate Drop Response" algorithm if available, which provides faster pacing when sudden rate drops are detected
Consider enabling "Sleep Mode" settings if appropriate

3. Comprehensive Medical Evaluation

Review all medications (especially those affecting heart rate or blood pressure)
Assess hydration status (evening fluid intake was primarily water and low-sodium beverages)
Consider tilt-table testing if diagnosis is uncertain
Evaluate potential need for a more advanced device (dual-chamber pacemaker) if atrial-ventricular dyssynchrony is a major contributor

Conclusion

The patient likely experienced a severe nocturnal vasovagal episode characterized by profound cardioinhibition (requiring very low backup pacing at 27 bpm) and significant vasodilation. The leadless pacemaker prevented cardiac arrest but could not prevent hypotensive consequences due to the low paced rate and lack of atrial support. The symptoms upon waking represent the recovery phase. This event warrants prompt cardiology review to prevent recurrence and optimize device therapy.

Disclaimer: This analysis is provided for informational purposes only and does not constitute medical advice. The patient should seek immediate evaluation from their healthcare provider. Device settings should only be adjusted by qualified electrophysiology professionals.